9 news items
Navigating 14 Analyst Ratings For Regeneron Pharmaceuticals
REGN
4 Jun 24
(NASDAQ:REGN), offering a diverse set of opinions from bullish to bearish.
The table below provides a snapshot of their recent
Biohaven Doses First Patient with its Novel Trop-2 Directed Antibody Drug Conjugate (ADC) BHV-1510 in Advanced or Metastatic Epithelial Tumors
BHVN
REGN
29 May 24
deep in-house expertise in oncology clinical development, ADC chemistry, and complex manufacturing, we believe our diverse and growing ADC portfolio
More than $9 Million Awarded to High School Scientists and Engineers at the Regeneron International Science and Engineering Fair 2024
REGN
17 May 24
by the ingenuity and determination shown by these remarkable students. Coming from around the world with diverse backgrounds and academic disciplines
More than $9 Million Awarded to High School Scientists and Engineers at the Regeneron International Science and Engineering Fair 2024
REGN
17 May 24
and determination shown by these remarkable students. Coming from around the world with diverse backgrounds and academic disciplines, these students have
More than $9 Million Awarded to High School Scientists and Engineers at the Regeneron International Science and Engineering Fair 2024
REGN
17 May 24
by the ingenuity and determination shown by these remarkable students. Coming from around the world with diverse backgrounds and academic disciplines
e0u9ernan7u75oiuls1ltlnl7rshwt639ddo3fpv6t3natc0wv6g49
REGN
24 Apr 24
multiple promising and distinct investigational treatment approaches for a diverse array of difficult-to-treat cancers," said George D. Yancopoulos
60gclu1yj1kioe6stechysp2bpc3v8y83ovru oq8fse2
REGN
12 Apr 24
(NASDAQ:REGN) over the past quarter, offering a diverse set of opinions from bullish to bearish.
The following table encapsulates
63b6946hlclerjrbyxk7 15vbkotkzdwvq4q1l6he4ujm6qc57bzi
REGN
7 Apr 24
VelociSuite® technologies to develop medicines for patients with diverse blood cancers and rare blood disorders. Our blood
ni3f 4dfor2n0ey4f2y4oqena
REGN
26 Mar 24
(NASDAQ:REGN) over the past quarter, offering a diverse set of opinions from bullish to bearish.
The table below provides a snapshot
- Prev
- 1
- Next